Medical ventilator

COVID-19 Pandemic Has Shown How 3D Printing Can Help to Shorten Supply Chains - ResearchAndMarkets.com

Retrieved on: 
Tuesday, June 23, 2020
Other Manufacturing, Manufacturing, Articles, Human activities, Contents, Emerging technologies, Industrial design, Industrial processes, Medical ventilator, Respiratory therapy, Formlabs, Personal protective equipment, 3D printing

The COVID-19 pandemic caused severe disruption to global supply chains and had a particular effect on the availability of essential medical and protective equipment.

Key Points: 
  • The COVID-19 pandemic caused severe disruption to global supply chains and had a particular effect on the availability of essential medical and protective equipment.
  • The 3D printing industry rushed to respond to these shortages by pivoting to the manufacture of personal protective equipment, face shields, ventilator parts and nasal swabs.
  • Formlabs used its 3D printers to manufacture nasal swabs for COVID-19 testing kits while Copper3d released open source plans for a 3D printable N-95 respirator.
  • As a result of the disruption caused by the pandemic, many businesses are re-evaluating their supply chain and manufacturing operations.

Cipla Launches CIPREMI (remdesivir Lyophilised Powder for Injection 100 mg), the Only U.S. FDA Approved Emergency Use Authorisation (EUA) Treatment for Patients With Severe COVID-19 Disease

Retrieved on: 
Monday, June 22, 2020
Health, Medicine, Respiratory therapy, Specialty drugs, Antivirals, Emergency Use Authorization, Gilead Sciences, Remdesivir, Food and Drug Administration, Mechanical ventilation, Medical ventilator

The U.S. FDA issued an Emergency Use Authorization (EUA) to Gilead Sciences Inc. for emergency use of remdesivir for the treatment of hospitalized 2019 coronavirus disease (COVID-19) patients.

Key Points: 
  • The U.S. FDA issued an Emergency Use Authorization (EUA) to Gilead Sciences Inc. for emergency use of remdesivir for the treatment of hospitalized 2019 coronavirus disease (COVID-19) patients.
  • It is the only U.S. FDA approved Emergency Use Authorisation (EUA) treatment for adult and paediatric patients hospitalized with suspected or laboratory confirmed COVID-19 infection.
  • In May, Gilead Sciences Inc. extended a voluntary non-exclusive license to Cipla to manufacture and market Cipla's generic version of remedisvir called CIPREMI.
  • Most of these patients were on oxygentherapy of which somewerereceivinghigh flow oxygenornon-invasive ventilation, and some were on a mechanical ventilator.

Homecare Ventilator Market 2020-2024 | Increasing Demand for Home Healthcare to Boost Growth | Technavio

Retrieved on: 
Thursday, June 18, 2020
Medical devices, Health, Respiratory therapy, Fisher & Paykel, Haier, Medical ventilator, Medtronic, Health, Companies

Our homecare ventilator market report covers the following areas:

Key Points: 
  • Our homecare ventilator market report covers the following areas:
    This study identifies increasing demand for interconnected medical devices as one of the prime reasons driving the homecare ventilator market growth during the next few years.
  • We provide a detailed analysis of vendors operating in the homecare ventilator market, including some of the vendors such as BMC Medical Co. Ltd., Dima Italia Srl, Drive DeVilbiss Healthcare, Fisher & Paykel Healthcare Corp. Ltd., Koninklijke Philips NV, Medtronic Plc, ResMed Inc., Servona GmbH, Siare Engineering International Group Srl, and Vyaire Medical Inc.
  • Backed with competitive intelligence and benchmarking, our research reports on the homecare ventilator market are designed to provide entry support, customer profile and M&As as well as go-to-market strategy support.
  • Register for a free trial today and gain instant access to 17,000+ market research reports.

CAE receives Health Canada certification for its life-saving CAE Air1™ ventilator

Retrieved on: 
Wednesday, June 17, 2020
CAE Inc., CAE, Medical ventilator, Companies, Economy of Canada

MONTREAL, June17, 2020 /PRNewswire/ -(NYSE: CAE) (TSX: CAE) CAE announced today that its CAE Air1 ventilator has been certified by Health Canada.

Key Points: 
  • MONTREAL, June17, 2020 /PRNewswire/ -(NYSE: CAE) (TSX: CAE) CAE announced today that its CAE Air1 ventilator has been certified by Health Canada.
  • "Since the beginning of the pandemic, CAE was the first to receive certification from Health Canada for an entirely new ventilator.
  • CAE will now start shipping hundreds of CAE Air1 ventilators to the Government of Canada every week.
  • To access the list of CAE Air1 suppliers / distributors/ collaborators in Canada: click here
    Video on the CAE Air1 ventilator: click here
    B-Roll on the CAE Air1 ventilator: click here
    High resolution photos can be downloaded at: https://www.cae.com/multimedia-centre/
    For more information about the CAE Air1 ventilator, visit caehealthcare.com/caeair1 .

Global Ventilator Market (2020 to 2030) - Major Driving Factors, Challenges, and Opportunities - ResearchAndMarkets.com

Retrieved on: 
Monday, June 15, 2020
Medical devices, Health, Medicine, Medical specialties, Respiratory therapy, Health care, Mechanical ventilation, Intensive care medicine, Emergency medicine, Medical ventilator

What are the opportunities and challenges faced by healthcare and non-healthcare companies within the global ventilator market?

Key Points: 
  • What are the opportunities and challenges faced by healthcare and non-healthcare companies within the global ventilator market?
  • What was the market share of each of the companies in mechanical ventilator and non-invasive ventilator segments of the global ventilator market in 2019?
  • What are the major driving factors, challenges, and opportunities for the global ventilator market?
  • What impact of large ventilator inventories on the global ventilator market is expected once the COVID-19 pandemic is over?

Global Ventilator Market to 2030 - COVID-19 Outbreak Lead to Rising Global Ventilator Demand - ResearchAndMarkets.com

Retrieved on: 
Friday, June 12, 2020
Medical devices, Health, Respiratory therapy, Medicine, Health care, Medical specialties, Medical ventilator

What are the major regulatory changes taking place in the global ventilator market pre-COVID-19, during COVID-19, and post-COVID-19?

Key Points: 
  • What are the major regulatory changes taking place in the global ventilator market pre-COVID-19, during COVID-19, and post-COVID-19?
  • What is the market value estimates of the leading segments of the global ventilator market in 2030?
  • What is the change witnessed in the growth rate of the global ventilator market from pre-COVID to post-COVID scenario?
  • What impact of large ventilator inventories on the global ventilator market is expected once the COVID-19 pandemic is over?

Global Ventilator Market : Analysis and Forecast, 2021-2030

Retrieved on: 
Wednesday, June 10, 2020
Medicine, Medical specialties, Respiratory therapy, Health care, Intensive care medicine, Emergency medicine, Medical ventilator, Mechanical ventilation, Pandemic

What are the opportunities and challenges faced by healthcare and non-healthcare companies within the global ventilator market?

Key Points: 
  • What are the opportunities and challenges faced by healthcare and non-healthcare companies within the global ventilator market?
  • What was the market share of each of the companies in mechanical ventilator and non-invasive ventilator segments of the global ventilator market in 2019?
  • What impact of large ventilator inventories on the global ventilator market is expected once the COVID-19 pandemic is over?
  • The global ventilator market is witnessing an exponential rise in the size of the market due to the ongoing COVID-19 pandemic.

BioMedInnovations LLC Announces U.S. Food and Drug Administration Has Granted Emergency Use Authorization to Manufacture and Distribute SuppleVent™, a Unique and Value-Added Ventilator Technology

Retrieved on: 
Tuesday, June 9, 2020
Medicine, Medical specialties, Respiratory therapy, Health care, Intensive care medicine, Battelle Memorial Institute, Ernest Lawrence, Lawrence Livermore National Laboratory, Positive end-expiratory pressure, Medical ventilator

"BMI is pleased with the FDA's decision, which underscores the applicability of the core technology in our organ perfusion system.

Key Points: 
  • "BMI is pleased with the FDA's decision, which underscores the applicability of the core technology in our organ perfusion system.
  • LLNL and BMI pursued a reversed design approach, a methodology guided by anticipated supply chains and ease of assembly.
  • With this mindset, the partnership brought a design forward to full test spanning clinically relevant PIP, PEEP, I:E, RR and FiO2.
  • The device is designed to accommodate a standard 22 mm ventilator circuit outfitted with either a mask or endotracheal tube.

Xoran Technologies announces partnership with MakeMedical for distribution of Ventilator Splitters

Retrieved on: 
Monday, June 8, 2020
Medicine, Medical specialties, Respiratory therapy, Health care, Medical ventilator

Designed to allow the use of a single ventilator by multiple individuals, VentMI can address current and future potential ventilator shortages in the wake of the COVID-19 global pandemic.

Key Points: 
  • Designed to allow the use of a single ventilator by multiple individuals, VentMI can address current and future potential ventilator shortages in the wake of the COVID-19 global pandemic.
  • "We were looking for innovative ways to potentially help hospitals preparing for a ventilator shortage during the pandemic and beyond.
  • The VentMI pressure regulator allows us to do just that, without compromising the health of our patients."
  • "Xoran has a long history of collaboration with University of Michigan faculty and surgeons, so our partnership with MakeMedical just makes sense.

Eight US Manufacturers Selected to Make NASA COVID-19 Ventilator

Retrieved on: 
Friday, May 29, 2020
Respiratory therapy, Medicine, Medical specialties, Health care, Medical ventilator, Emergency Use Authorization, Mechanical ventilation, Pulmonology, Intensive care medicine

WASHINGTON, May 29, 2020 /PRNewswire/ --After receiving more than 100 applications, NASA's Jet Propulsion Laboratory (JPL) in Southern California has selected eight U.S. manufacturers to make a new ventilator tailored for coronavirus (COVID-19) patients.

Key Points: 
  • WASHINGTON, May 29, 2020 /PRNewswire/ --After receiving more than 100 applications, NASA's Jet Propulsion Laboratory (JPL) in Southern California has selected eight U.S. manufacturers to make a new ventilator tailored for coronavirus (COVID-19) patients.
  • Called VITAL (Ventilator Intervention Technology Accessible Locally), the high-pressure ventilatorwas designed to use one-seventh the parts of a traditional ventilator, relying on parts already available in supply chains.
  • It offers a simpler, more affordable option for treating critical patients while freeing up traditional ventilators for those with the most severe COVID-19 symptoms.
  • The compressed-air design also has been submitted to the FDA for a ventilator Emergency Use Authorization and is currently under review.